IM
Immatics N.V.
IMTX · NASDAQ
$8.79 -0.57% (-$0.05)
1M -8.34%
Market Cap 1.01B €
P/E Ratio -
Div. Yield -
ROE 45.39%
Bulios Fair Price
$5.08
42.2% downside
Trenutna cena
$8.79
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica IMTX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
38 /100
Fair P/S 24.14x
P/B 2.53x
P/E N/A
Growth
22 /100
Declining Rev. growth 34.64%
Book val. growth 31.43%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 77.79%
Net margin 495.95%
FCF margin 501.62%
Quality
1 /100
Poor ROIC 52.79%
ROE 45.39%
Asset turnover 0.09x
Debt
69 /100
Low Debt/Equity 0.04x
Current ratio 7.54x
Int. coverage -242.90x
Stability
13 /100
Unstable Beta 1.32x
Rev. volatility 148.66%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IMTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Harpreet Singh
Employees
678
Headquarters
Tübingen
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report